Suchergebnisse - "Sulkowski, Mark S"

PubPharm (47)

1

Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1 : a Phase III, open-label study

enthalten in: Hepatology international | 2017

von Sulkowski, M. | Fessel, W. | Lazzarin, A. | +21

2

Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1 : pooled analysis of two phase 3 trials

enthalten in: Annals of hepatology | 2016

von Jensen, D. | Asselah, T. | Dieterich, D. | +27

3

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients : the COSMOS randomised study

enthalten in: Lancet (London, England) | 2014

von Lawitz, E. | Sulkowski, M. | Ghalib, R. | +19

ErratumIn: Lancet. 2014 Nov 15;384(9956):1748

4

Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients

enthalten in: Hepatology (Baltimore, Md.) | 2014

von Balagopal, A. | Kandathil, A. | Higgins, Y. | +8

5

Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1 : a combined analysis of 3 phase 2/3 clinical trials

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2014

von Manns, M. | McCone, J. | Davis, M. | +20

6

Infections during peginterferon/ribavirin therapy are associated with the magnitude of decline in absolute lymphocyte count : results of the IDEAL study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2014

von Melia, M. | Bräu, N. | Poordad, F. | +13

7

Predictors of consent to pharmacogenomics testing in the IDEAL study

enthalten in: Pharmacogenetics and genomics | 2013

von Jazwinski, A. | Clark, P. | Thompson, A. | +8

8

Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial

enthalten in: Gastroenterology | 2013

von Poordad, F. | Lawitz, E. | Reddy, K. | +127

CommentIn: Gastroenterology. 2013 Nov;145(5):930-3. - PMID 24060434

9

Analysis of site performance in academic-based and community-based centers in the IDEAL Study

enthalten in: Journal of clinical gastroenterology | 2013

von Jou, J. | Sulkowski, M. | Noviello, S. | +4

10

Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV : a randomized trial

enthalten in: Annals of internal medicine | 2013

von Sulkowski, M. | Sherman, K. | Dieterich, D. | +12

1
2
3
4
5
Nächster »
[5]